Ensysce Biosciences
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $493 | $1,371 | $1,320 | $1,303 |
Gross Profit | -2,461 | -551 | 1,320 | -2,498 |
EBITDA | 18 | -1,730 | -1,942 | -3,554 |
EBIT | -3,722 | -1,750 | -3,910 | -1,690 |
Net Income | -3,729 | -1,733 | -1,946 | -3,564 |
Net Change In Cash | 493 | 1,371 | 1,320 | 1,303 |
Free Cash Flow | -1,989 | -2,706 | -1,707 | -764 |
Cash | 1,673 | 2,211 | 3,052 | 3,502 |
Basic Shares | 2,886 | 2,202 | 1,401 | 1,229 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $5,210 | $2,231 | $2,523 | $3,531 |
Gross Profit | -2,009 | -5,357 | -17,312 | 3,531 |
EBITDA | -6,729 | -10,718 | -24,222 | -19,870 |
EBIT | -6,730 | -10,717 | -24,222 | -19,870 |
Net Income | -7,987 | -10,613 | -24,961 | -29,145 |
Net Change In Cash | 5,210 | 2,231 | 2,523 | 3,531 |
Free Cash Flow | -7,502,700,000 | -10,779 | -17,887 | -8,242 |
Cash | 3,502 | 1,123 | 3,147 | 12,264 |
Basic Shares | 1,747 | 2,264 | 179 | 84 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$1.29 |
2025-06-30 | -$0.79 |
2025-03-31 | -$1.39 |
2024-12-31 | -$2.90 |
